Back to results
US 2020/0270273 A1Published application
Heterocyclic amides as kinase inhibitors
AssigneeGlaxoSmithKline Intellectual Property Development Limited
InventorJae U. JEONG
Life of this patent
Estimating the term…
Abstract
Disclosed are compounds having Formula (I): wherein Q, X, A, L, B, Q4, R, RA, R5, n and m are as defined herein, and methods of making and using the same.
Claims22
A compound according to Formula (I):
- wherein:
- X is O, S, SO, SO2, NH, CO, CH2, CF2, CH(CH3), CH(OH), or N(CH3);
- Q is a 5-membered heteroaryl ring moiety, wherein the heteroaryl ring moiety contains one nitrogen, oxygen, or sulfur ring heteroatom, or contains one oxygen or sulfur ring heteroatom and 1, 2, or 3 nitrogen ring atoms or contains one nitrogen ring heteroatom and 2 or 3 additional nitrogen ring atoms;
- Q4 is N or C;
- n is 0-3;
- each R is independently selected from halogen, cyano, (C1-C6)alkyl, halo(C1-C4)alkyl, (C1-C6)alkoxy, halo(C1-C4)alkoxy, hydroxyl, —COOH, (C1-C4)alkoxy(C1-C4)alkoxy-, (C1-C4)alkylSO2-, (C1-C4)alkylSO2NHC(O)—, (C1-C4)alkylC(O)NH—, ((C1-C4)alkyl)((C1-C4)alkyl)NC(O)—, (C1-C4)alkylC(O)—, (C1-C4)alkylOC(O)—, (C1-C4)alkylC(O)N(C1-C4)alkyl)-, (C1-C4)alkylNHC(O)—, (C1-C4)alkoxy(C2-C4)alkylNHC(O)—, (C1-C4)alkoxy(C2-C4)alkylC(O)NH—, (C1-C4)alkoxy(C2-C4)alkylNHC(O)NH—, (C1-C4)alkylSO2(C2-C4)alkylNHC(O)—, (C1-C4)alkylNHC(O)NH—, (C1-C4)alkylOC(O)NH—, hydroxy(C1-C4)alkylOC(O)NH—, and an optionally substituted 3-6 membered cycloalkyl, (C3-C6)cycloalkyl-C(O)—, phenyl, phenyl-C(O)—, 5-6 membered heterocycloalkyl-C(O)—, 5-6 membered heterocycloalkyl-(C1-C4)alkyl-NHC(O)—, 5-6 membered heterocycloalkyl-(C1-C4)alkoxy-, 5-6 membered heteroaryl, 5-6 membered heteroaryl-C(O)—, or 5-6 membered heteroaryl-C(O)NH— group,
- wherein any of said optionally substituted 3-6 membered cycloalkyl, phenyl, 5-6 membered heterocycloalkyl and 5-6 membered heteroaryl, including the optionally substituted cycloalkyl, phenyl, 5-6 membered heterocycloalkyl and 5-6 membered heteroaryl moieties of the (C3-C6)cycloalkyl-C(O)—, phenyl-C(O)—, 5-6 membered heterocycloalkyl-C(O)—, 5-6 membered heterocycloalkyl-(C1-C4)alkyl-NHC(O)—, 5-6 membered heterocycloalkyl-(C1-C4)alkoxy-, 5-6 membered heteroaryl-C(O)—, or 5-6 membered heteroaryl-C(O)NH— groups, are optionally substituted by 1-3 substituents each independently selected from the group consisting of halogen, cyano, (C1-C6)alkyl, halo(C1-C4)alkyl, (C1-C6)alkoxy, halo(C1-C4)alkoxy, hydroxyl, —COOH, (C1-C4)alkoxy(C1-C4)alkoxy-, (C1-C4)alkylSO2-, (C1-C4)alkylSO2NHC(O)—, (C1-C4)alkylC(O)NH—, ((C1-C4)alkyl)((C1-C4)alkyl)NC(O)—, (C1-C4)alkylOC(O)—, (C1-C4)alkylC(O)N(C1-C4)alkyl)-, (C1-C4)alkylNHC(O)—, (C1-C4)alkoxy(C2-C4)alkylNHC(O)—, (C1-C4)alkoxy(C2-C4)alkylC(O)NH—, (C1-C4)alkoxy(C2-C4)alkylNHC(O)NH—, (C1-C4)alkylSO2(C2-C4)alkylNHC(O)—, (C1-C4)alkylNHC(O)NH—, (C1-C4)alkylOC(O)NH—, hydroxy(C1-C4)alkylOC(O)NH—, —NH2, —NH((C1-C4)alkyl), and —N((C1-C4)alkyl)((C1-C4)alkyl);
- or two R groups, taken together with the atoms through which they are connected form an optionally substituted 5-7 membered carbocyclic or heterocyclic ring, wherein the optionally substituted 5-7 membered carbocyclic or heterocyclic ring is optionally substituted by 1-3 substituents each independently selected from the group consisting of halogen, cyano, (C1-C6)alkyl, halo(C1-C4)alkyl, (C1-C6)alkoxy, halo(C1-C4)alkoxy, hydroxyl, —COOH, (C1-C4)alkoxy(C1-C4)alkoxy-, (C1-C4)alkylSO2-, (C1-C4)alkylSO2NHC(O)—, (C1-C4)alkylC(O)NH—, ((C1-C4)alkyl)((C1-C4)alkyl)NC(O)—, (C1-C4)alkylOC(O)—, (C1-C4)alkylC(O)N(C1-C4)alkyl)-, (C1-C4)alkylNHC(O)—, (C1-C4)alkoxy(C2-C4)alkylNHC(O)—, (C1-C4)alkoxy(C2-C4)alkylC(O)NH—, (C1-C4)alkoxy(C2-C4)alkylNHC(O)NH—, (C1-C4)alkylSO2(C2-C4)alkylNHC(O)—, (C1-C4)alkylNHC(O)NH—, (C1-C4)alkylOC(O)NH—, hydroxy(C1-C4)alkylOC(O)NH—, —NH2, —NH((C1-C4)alkyl), and —N((C1-C4)alkyl)((C1-C4)alkyl), and the 5-6 heterocyclic ring contains one N or O atom;
- R5 is H or methyl;
- A is phenyl, 5-6 membered heteroaryl, or 5-6 membered heterocycloalkyl, wherein the carbonyl moiety and L are substituted 1,3 on ring A;
- m is 0 or m is 1 and RA is (C1-C4)alkyl;
- and
- L is O, S, NH, N(CH3), CH2, CH2CH2, CH(CH3), CHF, CF2, CH2O, CH2N(CH3), CH2NH, or CH(OH);
- B is an optionally substituted (C3-C6)cycloalkyl, phenyl, 5-6 membered heteroaryl, or 5-6 membered heterocycloalkyl, wherein said (C3-C6)cycloalkyl, phenyl, 5-6 membered heteroaryl, or 5-6 membered heterocycloalkyl is unsubstituted or is substituted by one or two substituents each independently selected from halogen, (C1-C4)alkyl, halo(C1-C4)alkyl, (C1-C4)alkoxy, halo(C1-C4)alkoxy, nitro, and (C1-C4)alkylC(O)—;
- or the moiety -L-B is (C3-C6)alkyl, (C3-C6)alkoxy, halo(C3-C6)alkoxy, (C3-C6)alkenyl, or (C3-C6)alkenyloxy;
- or a salt thereof.
13 more elements
(canceled)
22-29. (canceled)
Dependencies are inferred from the claim text.